Delivery by Trypanosoma cruzi of Proteins into the MHC Class I Antigen Processing and Presentation Pathway

Journal of Immunology

Volumn 158, Issue 7, 1997, Pages 3293-3302

  Garg, Nisha ^a   Nunes, Marise P ^a,b   Tarleton, Rick L ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

H2 ANTIGEN; OVALBUMIN; PROTOZOAL PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ANTIGEN PRESENTATION; ARTICLE; C57BL MOUSE; CELL LINE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HOST PARASITE INTERACTION; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MOUSE; TRANSPORT AT THE CELLULAR LEVEL; TRYPANOSOMA CRUZI;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; BIOLOGICAL TRANSPORT; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; GENETIC VECTORS; H-2 ANTIGENS; HOST-PARASITE RELATIONS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; OVALBUMIN; PROTOZOAN PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TRYPANOSOMA CRUZI;

EID: 0031114082     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Santos-Buch, C. A., and A. M. Acosta. 1985. Pathology of Chagas disease. In Immunology and Pathology of Trypanosomiasis. I. Tizard, ed. CRC Press, Boca Raton, pp. 145-183.
2. Lages-Silva, E., L. E. Ramirez, A. U. Krettli, and Z. Brener. 1987. Effect of protective and non-protective antibodies in the phagocytosis rate of Trypanosoma cruzi blood forms by mouse peritoneal macrophages. Parasite Immunol. 9:21.
3. Lima-Martins, M. V. C., G. A. Sanchez, A. U. Krettli, and Z. Brener. 1985. Antibody-dependent cell cytotoxicity against Trypanosoma cruzi is only mediated by protective antibodies. Parasite Immunol. 7:367.
4. Celentano, A. M., and C. S. Gonzalez. 1992. Induction of macrophage activation and opsonizing antibodies by Trypanosoma cruzi subpopulations. Parasite Immunol. 14:155.
5. Nathan, C., N. Nogueira, C. Juanghanich, J. Ellis, and Z. Cohn. 1979. Activation of macrophages in vivo and in vitro: correlation between hydrogen peroxide release and killing of Trypanosoma cruzi. J. Exp. Med. 149:1056.
6. Russo, N., and N. Starobinas. 1991. Macrophage activation and resistance to Trypanosoma cruzi infection. Res. Immunol. 142:144.
7. + T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi. J. Immunol. 144:717.
8. Tarleton, R. L., B. H. Koller, A. Latour, and M. Postan. 1992. Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 356: 338.
9. Tarleton, R. L., M. J, Grusby, M. Postan, and L. H. Glimcher. 1996. Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I and class II-restricted T cells in immune resistance and disease. Int. Immunol. 8:13.
10. Rottenberg, M. E., M. Bakhiet, T. Olsson, K. Kristensson, T. Mak, H. Wigzell, and A. Orn. 1993. Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei. Infect. Immun. 61:5129.
11. Rottenberg, M. E., A. Riarte, L. Sporrong, J. Altcheh, P. Petray, A. M. Ruiz, H. Wigzell, and A. Orn. 1995. Outcome of infection with different strains of Trypanosoma cruzi in mice lacking CD4 and/or CD8. Immunol. Lett. 45:53.
12. Rottenberg, M. E., L. Sporrong, I. Persson, H. Wigzell, and A. Orn. 1995. Cytokine gene expression during infection of mice lacking CD4 and/or CD8 with Trypanosoma cruzi. Scand. J. Immunol. 41:164.
13. Kuhn, R. E., and J. E. Murnane. 1977. Trypanosoma cruzi: immune destruction of parasitized mouse fibroblast in vitro. Exp. Parasitol. 41:66.
14. Andrews, N. W., K.-S. Hong, E. S. Robbins, and V. Nussenzweig. 1987. Stage-specific surface antigens expressed during the morphogenesis of vertebrate forms of Trypanosoma cruzi. Exp. Parasitol. 64:474.
15. Pan, A. A., and D. McMahon-Pratt. 1989. Amastigote and epimastigote stage-specific components of Trypanosoma cruzi characterized by using monoclonal antibodies. J. Immunol. 143:1001.
16. Teixeira, S. M. R., D. G. Russell, L. V. Kirchhoff, and J. E. Donelson. 1994. A differentially expressed gene family encoding "Amastin," a surface protein of Trypanosoma cruzi amastigotes. J. Biol. Chem. 269:20509.
17. Gunning, P., I. Leavitt, G. Muscat, S. Ng, and L. Kedes. 1987. A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proc. Natl. Acad. Sci. USA 84:4831.
18. Moore, M. W., F. R. Carbone, and M. J. Bevan. 1988. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54:777.
19. Cooper, R., J. A. Inverso, M. Espinosa, N. Nogueira, and G. A. Cross. 1991. Characterization of a candidate gene for GP72, an insect stage-specific antigen of Trypanosoma cruzi. Mol. Biochem. Parasitol. 49:45.
20. Kelly, J. M., H. M. Ward, M. A. Miles, and G. Kendall. 1992. A shuttle vector which facilitates the expression of transfected genes in Trypanosoma cruzi and Leishmania. Nucleic Acids Res. 20:3963.
21. Yokota, T., N. Arai, F. Lee, D. Rennick, T. Mosmann, and K. Arai. 1985. Use of a cDNA expression vector for isolation of mouse interleukin 2 cDNA clones: expression of T-cell growth-factor activity after transfection of monkey cells. Proc. Natl. Acad. Sci. USA 82:68.
22. Teasdale, R. D., G. D'Agostaro, and P. A. Gleeson. 1992. The signal for Golgi retention of bovine β1,4-galactosyltransferase is the transmembrane domain. J. Biol. Chem. 267:4084.
23. Hernandez-Munain, C., M. A. Fernandez, A. Alcina, and M. Fresno. 1991. Characterization of a glycosyl-phosphatidylinositol-anchored membrane protein from Trypanosoma cruzi. Infect. Immun. 59:1409.
24. Mensa-Wilmot, K., J. H. LeBowitz, K. P. Chang, A. Al-Qahtani, B. S. McGwire, S. Tucker, and J. C. Morris. 1994. A glycosylphosphatidylinositol (GPI)-negative phenotype produced in Leishmania major by GPI phospholipase C from Trypanosoma brucei: topography of two GPI pathways. J. Cell Biol. 124:935.
25. Puddington, L., M. J. Bevan, J. K. Rose, and L. Lefrancois. 1986. N protein is the predominant antigen recognized by vesicular stomatitis virus-specific cytotoxic T cells. J. Virol. 60:708.
26. Carbone, F. C., and M. J. Bevan. 1990. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J. Exp. Med. 171:377.
27. Tarleton, R. L., and R. E. Kuhn. 1984. Loss of suppressor activity in the serum of mice infected with Trypanosoma cruzi. J. Parasitol. 70:253.
28. Restifo, N. P., I. Bacik, K. R. Irvine, J, W. Yewdell, B. J. McCabe, R. W. Anderson, L. C. Eisenlohr, S. A. Rosenberg, and J. R. Bennink. 1995. Antigen processing in vivo and the elicitation of primary CTL responses. J. Immunol. 154:4414.
29. La Flamme, A. C., F. C. Buckner, J. Swindle, J. Ajioka, and W. C. Van Voorhis. 1995. Expression of mammalian cytokines by Trypanosoma cruzi indicates unique signal sequence requirements and processing. Mol. Biochem. Parasitol. 75:25 .
30. Tarleton, R. L. 1996. Immunity to Trypanosoma cruzi. In Host Response to Intracellular Parasites. S. H. E. Kaufmann, ed. R. G. Landes Co., Austin, TX, pp 227-247.
31. + T lymphocytes in the inflammatory lesions of mice with acute Trypanosoma cruzi infection. Am. J. Trop. Med. Hyg. 48:161.
32. Tarleton, R. L., J. Sun, L. Zhang, and M. Postan. 1994. Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease. Infect. Immun. 62:1820.
33. +, MHC-restricted cytotoxic T cells that lyse parasite-infected target cells. J. Immunol. 150:1446.
34. Harty, J. T, and E. G. Pamer. 1995. CD8 T lymphocytes specific for the secreted p60 antigen protect against Listeria monocytogenes infection. J. Immunol. 154: 4642.
35. Horwitz, M. A., B. Esther, B. J. Dillon, and G. Harth. 1995. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 92:1530.
36. Hess, J., I. Gentschev, D. Miko, M. L. Welzel, C., W. Goebel, and S. Kaufmann. 1996. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc. Natl. Acad. Sci. USA 93:1458.
37. Andrews, N. W., E. S. Robbins, V. Ley, K. S. Hong, and V. Nussenzweig. 1988. Developmentally regulated, phospholipase C-mediated release of the major surface glycoprotein of Trypanosoma cruzi. J. Exp. Med. 167:300.
38. Couto, A. S., R. M. Lederkremer, W. Colli, and M. J. M. Alves. 1993. The glycosylphosphatidylinositol anchor of the trypomastigote-specific Tc-85 glycoprotein from Trypanosoma cruzi: metabolic labeling and structural studies. Eur. J. Biochem. 217:597.
39. Norris, K. A., and J. E. Scrimpf. 1994. Biochemical analysis of the membrane and soluble forms of the complement regulatory protein of Trypanosoma cruzi. Infect. Immun. 62:236.
40. + T cells are cytotoxic against Tomplasma gondii-infected peritoneal macrophages. J. Immunol. 148:1493.
41. + cytotoxic cells. J. Parasitol. 75:411.
42. Doolan, D. L., R. A. Houghten, and M. F. Good. 1991. Location of human cytotoxic T cell epitopes with a polymorphic domain of the Plasmodium falciparum circumsporozoite protein. Int. Immunol. 3:511.
43. Hill, A. V., J. Elvin, A. C. Wills, M. Aidoo, C. E. M. Allsopp, F. M. Gotch, X. M. Gao, M. Takiguchi, B. M. Greenwood, A. R. M. Townsend, A. J. McMichael, and H. C. Whittle. 1992. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360:434.
44. Plata, F., G. Milon, F. Garcia-Pons, and G. Marchai. 1986. Selective suppression of rumour-immune cytolytic T lymphocytes in mice with chronic Trypanosoma cruzi infections. Ann. Inst. Pasteur Immunol. 137D:47.